← The Wire
EDSANasdaq
Edesa Biotech, Inc.
Pharmaceutical Preparations · A1 · CIK 1540159
Edesa Biotech develops innovative drug candidates for inflammatory and immune-related diseases, focusing on dermatology and respiratory conditions
red 8-K · 90d
$52M
Market cap
$7.67
Last close
-6.3%
1D
+12.6%
5D
75K
Volume
Price · last 39 sessions-52.4%
May 4L $4.94 · H $17.43Jun 29
341
Total filings
Jun 11, 2026
Last filing
09/30
Fiscal year end
SC 13DSC 13DAug 19, 2019SC 13DSC 13DAug 19, 2019SC 13DSCHEDULE 13DJun 25, 2019SC 13DSC 13DJun 19, 2019SC 13DSC 13DJun 17, 2019SC 13DSC 13DJun 17, 2019SC 13DSC 13DJun 28, 2017SC 13DSCHEDULE 13DSep 29, 2014
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Mar 10, 2026: 2 insiders bought $233K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 1,000 | $6.60 | $7K |
| Mar 5, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 10,000 | $3.90 | $39K |
| Mar 4, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 10,000 | $4.26 | $43K |
| Mar 3, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 10,000 | $3.63 | $36K |
| Mar 2, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 2,000 | $2.00 | $4K |
| Mar 2, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 1,000 | $2.28 | $2K |
| Feb 27, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 30,000 | $2.22 | $67K |
| Feb 26, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 20,571 | $1.58 | $33K |
| Feb 26, 2026 | Brooks Michael JPresident | Buy | 2,000 | $1.57 | $3K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance